Sulfasalazine
Active substance: sulfasalazine
TABLET, DELAYED RELEASE · SULFASALAZINE 500 mg/1
United StatesActive
Marketing holder: Sunrise Pharmaceutical, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
- SULFASALAZINE · 500 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 12 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3edf-732f-9577-115f2cba4bf0,01a120c3-3f07-79b9-95c2-66dedff2c799,01a120c3-777e-7d1f-bd72-3e7744a2c8f6,01a120c3-bc42-7453-a4ae-ac477907c4d2,01a120c5-1dad-7340-b89b-7acbac4a43f9;count=9 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-8881-71bd-9909-2d664273998d,01a1208d-2d3f-723e-89d1-554a2a1c55d8,01a1208d-fee7-7bdb-b531-3569496afbbc,01a1208e-565a-7af7-a3d6-36692cfc558e,01a1208e-8c64-7d20-a294-494fe50ea3d5;count=14 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 11534-201
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 11534-201 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 11534-201 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 11534-201 · Verified 2026-10-09 · open in source